Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

    NEXT STORY
    Cytokinetics Announces Results From GALACTIC-HF Presented at Late Breaking Clinical Trial Session at the American Heart Association Scientific Sessions and Published in the New England Journal of Medicine
    PREV STORY
    CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Synairgen plc – Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in the illness

    author_avatar
    NASDAQ Market News

    Retrophin Reports Third Quarter 2016 Financial Results

    Positive top-line results from DUET announced in September; additional data to be presented at ...

    author_avatar
    NASDAQ Market News

    Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation

    author_avatar
    NASDAQ Market News